23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-60.65%
Negative revenue growth while Insurance - Life median is -0.16%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-60.65%
Negative gross profit growth while Insurance - Life median is -0.33%. Seth Klarman would suspect poor product pricing or inefficient production.
295.42%
EBIT growth of 295.42% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
295.42%
Positive operating income growth while Insurance - Life is negative. Peter Lynch would spot a big relative advantage here.
1847.83%
Net income growth exceeding 1.5x Insurance - Life median of 16.52%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
1848.69%
EPS growth exceeding 1.5x Insurance - Life median of 22.32%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
1843.16%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 22.32%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.23%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-14.23%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
-5.02%
Negative 10Y revenue/share CAGR while Insurance - Life median is 28.30%. Seth Klarman would see if the entire sector or just this company faces long-term decline.
-55.74%
Negative 5Y CAGR while Insurance - Life median is -0.80%. Seth Klarman would see if others are at least growing moderately, indicating a firm-specific problem.
-52.28%
Negative 3Y CAGR while Insurance - Life median is 5.13%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
2140.39%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 99.48% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
340.06%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 67.72%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
4.84%
3Y OCF/share growth of 4.84% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
259.96%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 105.56% over a decade. Joel Greenblatt might see a standout compounder of earnings.
22.12%
5Y net income/share CAGR > 1.5x Insurance - Life median of 1.76%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
212.92%
3Y net income/share CAGR > 1.5x Insurance - Life median of 55.35%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
167.87%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 38.29% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
-7.62%
Negative 5Y equity/share growth while Insurance - Life median is 0.00%. Seth Klarman suspects firm-specific weaknesses if peers grow equity mid-term.
-5.36%
Negative 3Y equity/share growth while Insurance - Life median is 6.41%. Seth Klarman sees a short-term weakness if peers still expand net worth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.26%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
0.69%
Asset growth 50-75% of Insurance - Life median. Guy Spier sees potential underinvestment or overcaution vs. peers.
3.80%
BV/share growth of 3.80% while Insurance - Life is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-0.56%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-4.71%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.